Oncology Clinical Trials

Recruiting oncology studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.

Clinical trials study new ways to prevent, detect, or treat oncology. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting oncology studies with sites across the US; use the location tools to find ones near you.

What to expect

Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.

Recruiting oncology trials

Within

PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria

for Prostate Cancer

Sponsor: Ahmadu Bello University

Sex: Male·Age: 18+·Accepts healthy volunteers

Code: NCT07733440

Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer

for Bladder Cancer

Sponsor: Chinese University of Hong Kong

Sex: All·Age: 18+

Code: NCT07095751

Mapping Patient Decision-making in Thyroid Cancer

for Thyroid Cancer

Sponsor: University of California, Los Angeles

Sex: All·Age: 18+

Code: NCT06411834

A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy

for Cancer

Sponsor: CHU de Quebec-Universite Laval

Sex: All·Age: 18+

Code: NCT05896371·Phase 1, Phase 2

The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp

for Shared Decision Making

Sponsor: Vejle Hospital

Sex: All·Age: 18+

Code: NCT05776381·Phase 2

MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma

for Multiple Myeloma

1 site in Burlington

Sponsor: University of Vermont Medical Center

Sex: All·Age: 18+

Code: NCT07783607

ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)

for Cancer

1 site in Indianapolis

Sponsor: Indiana University

Sex: All·Age: 18+

Code: NCT06900296

Connecting People With Cancer to Employment Support

for Cancer

Sponsor: University of Kansas Medical Center

Sex: All·Age: 18+

Code: NCT07027449

PulmoSalud: Multimodal Program for Prehabilitation and Early Home Rehabilitation in Patients With Lung Cancer

for Lung Cancer

Sponsor: FranciscoVeraSerrano

Sex: All·Age: 18+

Code: NCT07478276

Simulation-Based Patient Education to Address Radiotherapy-Related Anxiety in Cancer Patients (ARAISE)

for Neoplasms

Sponsor: University Medical Center Goettingen

Sex: All·Age: 18+

Code: NCT07721246

Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE

for Cancer

2 sites in Pittsburgh

Sponsor: University of Pittsburgh

Sex: All·Age: 21 - 100·Accepts healthy volunteers

Code: NCT05601206

Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer

for Breast Cancer

Sponsor: Hao Xu

Sex: Female·Age: All ages

Code: NCT07389200

Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer

for Breast Cancer

1 site in Burlington

Sponsor: University of Vermont Medical Center

Sex: Female·Age: 18+

Code: NCT07406594

Symptom Management to Improve Completion of Patient-reported Outcome Measures

for Malignant Solid Neoplasm

1 site in Detroit

Sponsor: Henry Ford Health System

Sex: All·Age: 18+

Code: NCT07723495

Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department

for Snoezelen

Sponsor: Centre Oscar Lambret

Sex: All·Age: 8 - 18

Code: NCT07202507

Apply to this trial

Developing Pilot Postoperative Guidelines for Improved Functional Outcomes After High-Risk Cancer Surgery

for Cancer

2 sites in Birmingham

Sponsor: University of Alabama at Birmingham

Sex: All·Age: 18+

Code: NCT07720089

TeamTalk: Improving Inter-professional Communication During Cancer Treatment

for Pediatric Cancer

1 site in St Louis

Sponsor: Washington University School of Medicine

Sex: All·Age: 18+

Code: NCT07083674

Improving Affordability in Cancer Care Through Economic Screening and Support (I-ACCESS)

for Cancer

4 sites incl. New York

Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All·Age: 18+

Code: NCT07664436

Pre-Clinic Visit Online Education for Thyroid Cancer

for Thyroid Cancer

Sponsor: Cedars-Sinai Medical Center

Sex: All·Age: 18+

Code: NCT07690839

Developing and Testing the Efficacy of AI-Chatbot-Based

for Breast Cancer

Sponsor: National Taiwan University Hospital

Sex: All·Age: 18+

Code: NCT07791368

Combination Immunotherapy Targeting Sarcomas

for Sarcoma

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 1 - 75

Code: NCT04433221·Phase 1, Phase 2

EmpowerHer: Hybrid Digital Intervention for Breast Cancer Survivors

for Breast Cancer

Sponsor: University of Valencia

Sex: Female·Age: 18 - 65

Code: NCT07676591

Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

for Triple Negative Breast Cancer

1 site in Birmingham

Sponsor: University of Alabama at Birmingham

Sex: Female·Age: 18 - 75

Code: NCT04861077·EARLY_Phase 1

Apply to this trial

Universal 4SCAR7U Targeting CD7-positive Malignancies

for T-cell Acute Lymphoblastic Leukemia

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 6 Months - 75

Code: NCT05995028·Phase 1

Universal CAR-T Cells Targeting AML

for Acute Myeloid Leukemia

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 6 Months - 75

Code: NCT05995041·Phase 1

A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods

for Cancer

Sponsor: University of Sydney

Sex: All·Age: 18+

Code: NCT06708221

Combination Immunotherapy Targeting Melanoma

for Melanoma

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 18 - 75

Code: NCT06739226·Phase 1, Phase 2

Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment

for Cancer

1 site in Galveston

Sponsor: The University of Texas Medical Branch, Galveston

Sex: Female·Age: 30 - 50

Code: NCT06800092·Phase 2, Phase 3

Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation

for Pancreatic Cancer

Sponsor: Jiangxi Kvvit Pharmaceutical Co., Ltd.

Sex: All·Age: 18 - 75

Code: NCT07656376·Phase 2, Phase 3

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

for Sarcoma

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 1 - 75

Code: NCT03356782·Phase 1, Phase 2

Antigen-specific T Cells Against Lung Cancer

for Lung Cancer

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 18 - 80

Code: NCT03356808·Phase 1, Phase 2

Immunotherapy Treating GI Cancer

for Cancer

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 1 - 80

Code: NCT03614650·Phase 1, Phase 2

Multi-4SCAR-T Therapy Targeting Breast Cancer

for Breast Cancer

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 18 - 75

Code: NCT04430595·Phase 1, Phase 2

Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

for Solid Tumor

Sponsor: Shenzhen Geno-Immune Medical Institute

Sex: All·Age: 1 - 75

Code: NCT04432649·Phase 1, Phase 2

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

for Multiple Myeloma

1 site in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18 - 70

Code: NCT04579523·Phase 1

Korea Post Marketing Surveillance (PMS) Study of Talzenna®

for Breast Neoplasms

Sponsor: Pfizer

Sex: All·Age: 19+

Code: NCT04982848

A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

for Prostate Carcinoma

1 site in Jacksonville

Sponsor: Mayo Clinic

Sex: Male·Age: All ages

Code: NCT07126548

Early Intervention

for Breast Cancer

1 site in Boston

Sponsor: Massachusetts General Hospital

Sex: Female·Age: 18+

Code: NCT05326165

Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)

for Cervical Cancer Screening

Sponsor: Boston Medical Center

Sex: Female·Age: 21 - 65

Code: NCT07226037

Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

for High Grade Sarcoma

1 site in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: All ages

Code: NCT07650656·Phase 2

Apply to this trial

A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)

for Myelodysplastic Syndromes

Sponsor: Kyntra Bio

Sex: All·Age: 18+

Code: NCT07722988·Phase 3

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

27 sites incl. Bloomington

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 60+

Code: NCT07437950·Phase 2

Apply to this trial

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

for Recurrent Multiple Myeloma

1 site in Philadelphia

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07463807·Phase 1, Phase 2

Apply to this trial

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

for Acute Myeloid Leukemia With Complex Karyotype

1 site in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07582172·Phase 2

Apply to this trial

Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records

for Lung Cancer

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06842056

Information-providing Chatbot

for Sarcoma

Sponsor: The Hong Kong Polytechnic University

Sex: All·Age: 18+

Code: NCT07505732

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

for Waldenstrom Macroglobulinaemia

Sponsor: Anne Louise Tølbøll Sørensen

Sex: All·Age: 18+

Code: NCT07474961·Phase 4

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

for Grade 2 IDH1-mutant Glioma

7 sites incl. Los Angeles

Sponsor: Nuvation Bio Inc.

Sex: All·Age: 18+

Code: NCT07703436·Phase 2

Aberrant Expression of CD56 in Patients With Hematologic Malignancies.

for Hematologic Malignancies

Sponsor: Asmaa Hassan mohamed Abdel Mawjoud

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT04546945

Apply to this trial

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

for Lung Non-Small Cell Carcinoma

59 sites incl. Beverly Hills

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07388524·Phase 3

Apply to this trial

Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI

for Carcinoma, Non-Small-Cell Lung

Sponsor: Xemed LLC

Sex: All·Age: 18 - 85

Code: NCT07355231·Phase 1, Phase 2

Maximizing Quality of Life After Cancer Through Rehabilitation

for Head and Neck Cancer

3 sites incl. Durham

Sponsor: VA Office of Research and Development

Sex: All·Age: 18 - 89

Code: NCT07622407

Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG

for High Grade Glioma

Sponsor: Nationwide Children's Hospital

Sex: All·Age: 12 - 39

Code: NCT07644312·Phase 2

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

for Chronic Graft Versus Host Disease

1 site in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07733141

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

for Anatomic Stage I Breast Cancer AJCC v8

11 sites incl. Arcadia

Sponsor: City of Hope Medical Center

Sex: Female·Age: 18+

Code: NCT07741968

Apply to this trial

FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma

for Glioblastoma

1 site in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07791264·Phase 1

The High Fiber Program to Increase Fiber Intake Among Patients Undergoing Allogeneic Hematopoietic Cell Transplant

for Hematopoietic and Lymphatic System Neoplasm

1 site in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07664670

Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphoma

for Randomized

1 site in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07783594·Phase 2

A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

for Squamous Cell Carcinoma

1 site in Chicago

Sponsor: University of Chicago

Sex: All·Age: 18+

Code: NCT07346196·Phase 2

Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer

for Gastric Cancer

Sponsor: Liu Yang

Sex: All·Age: 18 - 80

Code: NCT07697079

New trials in Boston, MA?

Pick a condition and we'll email you once a week when a new study starts recruiting in Boston, MA. Unsubscribe anytime.

Oncology clinical trials — common questions

Are oncology clinical trials free to join?

Yes. Participating in a oncology clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.

Who can join a oncology clinical trial?

Each oncology study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.

How do I find a oncology trial near me?

Use the location controls above. We'll show recruiting oncology trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.

How many oncology trials are recruiting right now?

We're currently tracking roughly 7430 recruiting oncology trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.

Looking for a specific location? Browse trials by city and state.

Oncology trials by city

Boston, MA Los Angeles, CA Duarte, CA Birmingham, AL San Francisco, CA Chicago, IL Miami, FL Aurora, CO Tampa, FL Seattle, WA Columbus, OH Cleveland, OH

Conditions in this area

Breast cancer Metastatic breast cancer Triple-negative breast cancer HER2-positive breast cancer HER2-negative breast cancer Lung cancer Non-small cell lung cancer (NSCLC)Small cell lung cancer Colorectal cancer Metastatic colorectal cancer Colon cancer Rectal cancer Pancreatic cancer Gastric cancer Esophageal cancer Gastroesophageal junction cancer